- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Cryopreservation.
Displaying page 1 of 1.
EudraCT Number: 2006-003813-42 | Sponsor Protocol Number: 107015 | Start Date*: 2006-12-21 |
Sponsor Name:NV Organon | ||
Full Title: Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 | ||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000926-21 | Sponsor Protocol Number: AMSC-BDT-002 | Start Date*: 2016-10-06 | |||||||||||
Sponsor Name:Fakultní nemocnice Hradec Králové | |||||||||||||
Full Title: Innovation of method cryopreservation for clinical use autologous multipotent mesenchymal stem cells (MSCs) for treatment of extensive skeletal defects in revision surgery of total hip arthroplasty+ | |||||||||||||
Medical condition: Revision total hip arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005474-11 | Sponsor Protocol Number: Pro.V.En | Start Date*: 2015-08-18 | |||||||||||
Sponsor Name:USS Centro di Fisiopatologia della Riproduzione, A.O. Papa Giovanni XXIII | |||||||||||||
Full Title: Pilot clinical study multicenter, prospective, randomized, open, non-profit to evaluate the efficacy of progesterone administered with different dose subcutaneously compared to progesterone adminis... | |||||||||||||
Medical condition: Women undergoing assisted reproduction with autologous cryopreserved embryo transfer. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000608-16 | Sponsor Protocol Number: 5466 | Start Date*: 2011-12-21 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust [...] | ||
Full Title: To evaluate the safety and effectiveness of human ex vivo expanded autologous limbal stem cells for the treatment of unilateral total limbal stem cell deficiency | ||
Medical condition: unilateral total limbal stem cell deficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004773-28 | Sponsor Protocol Number: 38831 | Start Date*: 2006-06-30 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 38819 | |||||||||||||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) SE (Completed) ES (Completed) BE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000230-39 | Sponsor Protocol Number: FOG 2006 | Start Date*: 2008-04-14 |
Sponsor Name:Endocrine Society of Czech Republic | ||
Full Title: Protective effect of gonadoliberin analogues on endocrine and reproduction ovarian function during antitumour treatment in young girls and women in fertile period: Project of pharmacological gonada... | ||
Medical condition: The patient with diagnosis: Hodgkin disease and leukaemia. Patients starting at adolescence (B3 - B4 for breast development accordig Tanner criteria) till 34 years be included. ... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005005-12 | Sponsor Protocol Number: D2.D12.Bemfola | Start Date*: 2018-05-28 | ||||||||||||||||
Sponsor Name:UZ Brussel | ||||||||||||||||||
Full Title: Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | ||||||||||||||||||
Medical condition: Subfertility Oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004458-27 | Sponsor Protocol Number: Krypto-3 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Optimizing the fertility potential of bilateral cryptorchidism by treatment with adjuvant kryptocur. | |||||||||||||
Medical condition: Cryptorchidism | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005208-20 | Sponsor Protocol Number: 2019DEPO-TRIGGER001 | Start Date*: 2022-08-10 | |||||||||||
Sponsor Name:Universitair Ziekenhuis Brussel | |||||||||||||
Full Title: Depo-Trigger trial: GnRH agonist DEPOt TRIGGER for final oocyte maturation in breast cancer patients undergoing fertility preservation: a pilot study. | |||||||||||||
Medical condition: Female patients with breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014601-13 | Sponsor Protocol Number: FPR-09-01 | Start Date*: 2010-12-17 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: Fertility preservation in patients with breast cancer. | ||||||||||||||||||
Medical condition: Fertility preservation in patients with breast cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004441-32 | Sponsor Protocol Number: MSV-crio | Start Date*: 2013-03-06 | |||||||||||
Sponsor Name:Fundación Teknon | |||||||||||||
Full Title: Pilot clinical trial to determine the feasibility and safety of MSV * cryopreserved in the treatment of gonartrosis. * MSV = mesenchymal progenitor cells of expanded autologous bone marrow with GMP... | |||||||||||||
Medical condition: Patients diagnosed with gonarthrosis II, III and IV degrees of Kellgren and Lawrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003843-30 | Sponsor Protocol Number: 26866138MMY2029 | Start Date*: 2006-01-05 |
Sponsor Name:ORTHO BIOTECH, Division of JANSSEN-CILAG GmbH | ||
Full Title: Bortezomib and Bendamustine in the Treatment of Refractory/Relapsed Multiple Myeloma | ||
Medical condition: Cytologically and/or histologically established multiple myeloma requiring treatment, stage II or III (Salmon and Durie). 1. - 3. Relapse or progression with measurable myeloma protein in the bloo... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-003949-14 | Sponsor Protocol Number: 26866138LYM2021 | Start Date*: 2008-08-18 | |||||||||||
Sponsor Name:ORTHO BIOTECH, Geschäftsbereich der JANSSEN-CILAG GmbH | |||||||||||||
Full Title: Pilot study of bortezomib under rituximab standard therapy in patients with relapsed or refractory follicular lymphoma and at least 2 prior therapies | |||||||||||||
Medical condition: Patients with histologically proven CD-20-positive follicular lymphoma grade I/II (WHO), stage III/IV (ANN ARBOR) relapsed or refractory to last treatment after at least 2 cytostatic therapies who ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001989-10 | Sponsor Protocol Number: CPI0610-04 | Start Date*: 2021-01-08 | ||||||||||||||||||||||||||
Sponsor Name:Constellation Pharmaceuticals, Inc. | ||||||||||||||||||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Active-Control Study of CPI-0610 and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients | ||||||||||||||||||||||||||||
Medical condition: Myelofibrosis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) HU (Ongoing) DE (Ongoing) AT (Ongoing) PL (Ongoing) CZ (Ongoing) NL (Ongoing) BE (Ongoing) IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003572-23 | Sponsor Protocol Number: GCP#01.01.030 | Start Date*: 2017-12-27 | ||||||||||||||||
Sponsor Name:Gamida Cell Ltd | ||||||||||||||||||
Full Title: Allogeneic Stem Cell Transplantation of CordIn™, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients with Hemoglobinopathies | ||||||||||||||||||
Medical condition: Hemoglobinopathies | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000074-19 | Sponsor Protocol Number: GCP#03.01.020 | Start Date*: 2014-10-24 | |||||||||||||||||||||||||||||||
Sponsor Name:Gamida Cell Ltd | |||||||||||||||||||||||||||||||||
Full Title: Full title of the trial: Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescents and Adult Patients with Hematologic... | |||||||||||||||||||||||||||||||||
Medical condition: High risk haematological malignancies | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: ES (Completed) IT (Completed) NL (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-005159-14 | Sponsor Protocol Number: GC P#02.01.001 | Start Date*: 2008-04-15 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Gamida Cell-Teva Joint Venture Ltd. | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in ... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: High-risk haematological malignancies (including AML, ALL, CML, NHL, HD, and MDS) with an indication for allogeneic haematopoietic stem cell transplantation, to support haematopoietic reconstitutio... | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Completed) IT (Completed) HU (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.